About Jeremy Wohlwend
Jeremy Wohlwend is cofounder and chief technology officer at Boltz. Boltz is a public benefit corporation. It builds open-source biomolecular models, including Boltz-1, Boltz-2 and BoltzGen, and a platform called Boltz Lab. Wohlwend helps build the company's molecular design models and tools. Boltz announced its launch on January 8, 2026, together with a $28 million seed round.
Wohlwend completed a PhD at MIT, advised by Regina Barzilay. As an MIT electrical engineering and computer science graduate student, he was a lead developer of Boltz-1, with Gabriele Corso. The MIT Jameel Clinic announced Boltz-1, an open-source model of biomolecular interactions, on November 16, 2024.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Jeremy Wohlwend in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeremy Wohlwend works with at each company, as listed on that company's latest Form D.
